Athenex to Present at the 39th Annual J.P. Morgan Healthcare Conference
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Athenex to Present at the 39th Annual J.P. Morgan Healthcare Conference Athenex, Inc.January 5, 2021 GMT BUFFALO, N.Y., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, announced that it will participate in the 39th annual J. P. Morgan Healthcare Conference. Johnson Lau, CEO and Board Chairman, and Daniel Lang, Senior...